Mandate

Vinge advised Fortum Värme in connection with the Swedish Competition Authority’s three-year investigation regarding the price of district heating in Stockholm

November 15, 2010

Since October 2007 the Swedish Competition Authority has investigated whether Fortum Värme, jointly owned by Fortum and the City of Stockholm, abused a dominant position in breach of the Swedish Competition Act by imposing unfairly high prices (excessive pricing) on its district heating customers in the Stockholm area. The Competition Authority has, by its unconditional decision on 12 November 2010, now closed the extensive and detailed investigation without any further actions. Fortum Värme has, during the investigation, declared its intention to ensure, for 2011, that the revenues generated from its district heating operations in Stockholm do not exceed a revenue cap defined by the company.     

Vinge’s competition team included responsible partner Johan Karlsson and several associates, including Carl Johan Sundqvist and Emil Fahlén Godö. Part of the team was also associate professor Mattias Ganslandt who, inter alia, contributed with several economic reports concerning the market for district heating and Fortum Värme’s pricing.

The Swedish Competition Authority’s decision and press release

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026